BAM Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
BAM Wealth Management's ABBV Position: Q3 2026 in Review
BAM Wealth Management increased its AbbVie (ABBV) stake by 52% in Q3 2026, buying an estimated $180K and bringing the position to 2,053 shares worth $537K. The position accounts for 0.29% of the portfolio, ranked #88.
BAM Wealth Management first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- BAM Wealth Management held 2,053 shares of AbbVie worth $537K as of Q3 2026.
- BAM Wealth Management bought 704 AbbVie shares in Q3 2026, an estimated $180K.
- AbbVie made up 0.29% of BAM Wealth Management's portfolio in Q3 2026, its #88 holding.
- BAM Wealth Management first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
- 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on BAM Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.